Nantahala Capital Management, LLC 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:09 pm Purchase | 2025-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Nantahala Capital Management, LLC | 2,449,468 2.800% | 205,149 (+9.14%) | Filing |
| 2025-11-14 4:39 pm Purchase | 2025-09-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Nantahala Capital Management, LLC | 2,244,319 9.990% | 2,244,319 (New Position) | Filing |